Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia

Erstveröffentlichung
2014Authors
Dawson, M. A.
Gudgin, E. J.
Horton, S. J.
Giotopoulos, G.
Meduri, E.
Wissenschaftlicher Artikel
Published in
Leukemia ; 28 (2014), 2. - S. 311-320. - ISSN 0887-6924. - eISSN 1476-5551
Link to publication
https://dx.doi.org/10.1038/leu.2013.338Institutions
UKU. Klinik für Innere Medizin IIISubject headings
[Free subject headings]: acute myeloid leukemia | epigenetic therapy | BET protein | nucleophosmin mutation | biomarker | GENE-EXPRESSION PROFILE | CYTOPLASMIC NUCLEOPHOSMIN | MUTANT NUCLEOPHOSMIN | INHIBITION | TARGET[DDC subject group]: DDC 610 / Medicine & health